The Research and Development Scientists at Solid Biosciences are dedicated to advancing innovative therapies for Duchenne muscular dystrophy (DMD). This team conducts cutting-edge research, develops and optimizes experimental protocols, and collaborates on preclinical studies to enhance understanding of DMD pathophysiology. Their efforts aim to translate scientific discoveries into effective treatments, ensuring the progression from lab discoveries to clinical applications.
View all